| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |